ASH Annual Meeting 2025

Location: Orlando, Florida

Date:

Event description:

Now in its 67th year, ASH remains the leading global forum for advances in classical and malignant hematology. With experience supporting 80+ blood disease clinical trials across all phases in APAC, North America, and Europe, Novotech brings deep regional expertise and global delivery capabilities to every hematology program. Our team will be on-site to discuss study planning and feasibility, regional start-up and regulatory strategies, site engagement, and data/biostatistics solutions—all designed to accelerate enrollment and streamline delivery for sponsors advancing hematology innovation.

Novotech Attendees:

  • Sarah Anderson — Director, Therapeutic Strategy
  • Pedro Rodriguez-Noriega — Associate Therapeutic Strategy Manager
  • Craig Leach — Associate Business Development Director

If you’d like to connect with our hematology team in Orlando, please request a meeting via the form on this page. 

This event has concluded

Thank you for your interest in Novotech at this event. While the event has ended, our experts continue to support sponsors across all stages of clinical development.

Have a question or want to continue the conversation?

Talk to a Clinical Development Expert

Meet Our Team

Novotech

Sarah Anderson

Novotech
Therapeutic Strategy Director
Novotech

Pedro Rodriguez-Noriega

Novotech
Associate Therapeutic Strategy Manager
Novotech

Craig Leach

Novotech
Associate Business Development Director